Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,200Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10MYLAN IRELAND LTD

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 11484531

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-10-23

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 12285417

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-29

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 12048692

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-29

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 11008289

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-14

blank

05

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 11858898

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-14

blank

06

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 10550081

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 210598

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-14

blank

07

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 9765028

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 210598

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-14

blank

08

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 8541451

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 210598

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-08-25

blank

09

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 11691948

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210598

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-14

blank

10

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

REVEFENACIN

US Patent Number : 7288657

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 210598

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-10-31

blank